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Objectives. Varicose veins are dilated tortuous veins of varying tone. Purinergic signalling is important in the control of
tone and in mediating trophic changes in blood vessels. The expression of P2 receptors in control and varicose veins will be
examined.
Methods. Purinergic signalling in circular and longitudinal smooth muscle of the human long saphenous vein was
studied in control and varicose tissues using immunohistochemistry, organ bath pharmacology and electron microscopy.
Results. P2X1, P2Y1, P2Y2, P2Y4 and P2Y6 receptors were present on circular and longitudinal smooth muscle. Purine-
mediated circular and longitudinal muscle contractions were weaker in varicose veins. Electron microscopy and immuno-
histochemistry findings support the view that smooth muscle cells change from the contractile to synthetic phenotype in
varicose veins, associated with an upregulation of P2Y1 and P2Y2 receptors and a down regulation of P2X1 receptors.
Conclusions. Down regulation of P2X1 receptors on the smooth muscle of varicose veins is associated with loss of
contractile activity. Upregulation of P2Y1 and P2Y2 receptors is associated with a shift from contractile to synthetic
and/or proliferative roles. The phenotype change in smooth muscle is associated with weakening of vein walls and may
be a causal factor in the development of varicose veins.
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The long saphenous vein (LSV) is the most widely
used autogenous venous graft due to its thick walls,
free availability and being the longest in the body.
However, it commonly becomes varicose and, due to
chronic venous insufficiency, leads to venous ulcera-
tion.1 It is a three-layered structure with an intima,
media and outer adventitia. Varicose perivascular
nerve fibres lie at the adventitia-medial border and
form neuroeffector junctions. The smooth muscle cells
(SMC) are in electrical continuity with each other via
gap junctions.2
Varicose veins are dilated, tortuous, thickened
veins, with wall structures varying from hypertrophic
to atrophic. In atrophic regions the medial SMC and
extracellular matrix (ECM) are diminished, leaving
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In hypertrophic regions the organisation is disturbed;
smooth muscle bundles lose their longitudinal and
circular direction, fibrous tissue accumulates, and in-
creases in ECM and vasa vasorum occur. There is
both hyperplasia and hypertrophy of the intimal
SMC.3,4 These changes are consistent with a change
from a contractile to a synthetic phenotype.3 There is
also evidence that SMC have taken up a phagocytic
role.4
Varicose veins have incompetent venous valves,
but an inherent weakness of the muscle wall due to
defective smooth muscle and connective tissue meta-
bolism is a contributing factor resulting in vessel dila-
tation and separation of valve leaflets.1,5 Similar
structural, biochemical and functional changes in var-
icose tributaries and in non-varicose veins from the
same patient6 suggested that abnormalities within
the vein wall exist before the varicosities develop.
Purinergic signalling, where purine nucleotides
and nucleosides act as extracellular messengers,
have important roles within the cardiovascularrved.
240 M. J. Metcalfe et al.system.7 Purines are cotransmitters with noradrena-
line (NA) mediating vasoconstriction. Long term
(trophic) changes of SMC and endothelial cells also
occur.8 Receptors to purines and pyrimidines are di-
vided into P1 (adenosine) receptors and P2 (purine/
pyrimidine) receptors.9 P2 receptors are subdivided
into seven P2X(1e7) ligand-gated ion channel receptors
and eight P2Y(1, 2, 4, 6, 11, 12, 13, 14)
10 receptors coupled
to G proteins.7,11 The P2Y12 receptor antagonist, clopi-
dogrel, is an antithrombotic drug, and adenosine acts
on A1 receptors on the atrioventricular node inhibit-
ing supraventricular tachycardia.12,13
Purinergic signalling has been demonstrated in the
LSV.14,15 Purine-mediated contractions on varicose
veins were compared with veins from atherosclerotic
legs,16 although not with healthy LSV. Previous phar-
macological studies have only examined the circular
muscle. Immunohistochemical studies have described
the presence of longitudinal muscle but its contractile
function is unknown.17 This study aimed to examine
the expression of P2 receptor subtypes in healthy
and varicose human LSV and compare the contractile
effects mediated by these receptors in circular and
longitudinal smooth muscle. Vein wall ultrastructure,
with particular emphasis on smooth muscle pheno-
type, was also studied.
Patients
Proximal end varicose vein segments were obtained
from 31 patients (19 female, 12 male, aged 21e77,
mean age 46.8 2.6 years) undergoing stripping of
their LSV. The most proximal end of the sample was
obtained prior to insertion of the stripper. Reflux
was confirmed by hand held doppler or venous du-
plex scanning. Healthy control vein was obtained
from 34 patients (6 female, 28 male, aged 41e84,
mean age 63.6 1.6 years) undergoing coronary ar-
tery bypass surgery. A segment from the proximal
end of the LSV was excised. Diabetic patients and con-
trol patients with reflux were excluded. Ethics ap-
proval was obtained by the joint UCL/ULCH Ethics
Committees on Human Research and by the Royal
Free Hampstead Research Ethics Committee.
Methods
Immunohistochemistry
Sampleswere collected inHanks balanced salt solution
(HBSS; Invitrogen,Paisley,UK) and frozen inprecooled
isopentane. Cryostat cut sections (10 mm) (Reichert
Jung CM1800) were collected on gelatine-coated slides,Eur J Vasc Endovasc Surg Vol 33, February 2007air dried at room temperature, fixed for 4 min in 4%
formaldehyde in 0.1 M phosphate buffer solution
(PBS) containing 0.2% picric acid, then washed
(3 5 min) with PBS. Sections were blocked for
60 min in 10% normal horse serum (NHS) in 0.1 M
PBS, containing 0.05%merthiolate. Sections were incu-
bated overnight with two primary antibodies: poly-
clonal P2X (P2X1e6) (Roche Palo Alto, CA, USA) or
P2Y (P2Y1, P2Y2, P2Y4, P2Y6, P2Y11) (Alomone Labora-
tories, Jerusalem, Israel) antibodies (1:50e1:200), and
monoclonal anti a-smooth muscle actin antibody
(Sigma Chemical Co., Poole, UK; 1:400) in 10% NHS
in PBS with 0.05% merthiolate. On day 2, sections
were washed (3 5 min) in PBS and stained with the
secondary antibodies: donkey anti-rabbit Cy3 (Jackson
Immunoresearch Laboratories, West Grove, USA;
1:300) and donkey anti-mouse FITC (Jackson; 1:200)
in PBS-merthiolate for 60 min. Sections were washed
(3 5 min) and mounted in Citifluor (Citifluor Ltd,
London, UK). Preabsorption control experiments
were performed with the corresponding peptide.
Semi-quantitative assessment of the changes in
immunofluorescent intensity were performed by an
independent observer, blinded from the patient group
from which samples were taken.
Haematoxylin and Eosin (H&E) slides were pre-
pared by fixing in 4% paraformaldehyde in PBS for
10 min. Sections were washed in distilled water then
stained for 20 min in Ehrlichs Haematoxylin. Follow-
ing washing in running tap water, slides were dipped
in acid alcohol and washed again for 15 min. Sections
were then stained in Eosin for 5 min, dipped in tap
water, then washed for 1 min in 70% alcohol, 3 min
100% alcohol, another 3 min 100% alcohol, dried for
3 min in xylene, and finally another 5 min in xylene.
Sections were mounted in Eukitt.
Staining was photographed using a Zeiss Axioplan
light microscope (Zeiss, Oberkochen, Germany)
mounted with a Leica DC 200 digital camera (Leica,
Heerbrugg, Switzerland).
Electron microscopy
Vein segments were collected and transported in
HBSS then fixed in 2% paraformaldehyde, 2% glutar-
aldehyde in 0.1 M phosphate solution. Tissue was
washed in phosphate buffer, post-fixed in 1% osmium
tetroxide in phosphate buffer, en-block stained with
a 2% solution of uranyl acetate in distilled water, de-
hydrated in graded ethanols and embedded in an
agar resin. Sections (80 nm) were cut and collected
on thin films, counterstained with lead citrate and
viewed in a Jeol 1010 TEM.
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Tissues were collected in Krebs solution (pH 7.2; mM):
NaCl 133, KCl 4.7, NaH2PO4 1.35, NaHCO3 16.3,
MgSO4 0.61, CaCl2 2.52 and glucose 7.8. Connective
tissue was removed and the vessels mounted horizon-
tally to examine circular muscle (by inserting 2 tung-
sten wires through the lumen, one attached to
a support the other to a Grass FTO3C transducer) or
vertically to examine longitudinal muscle (by using
a 15 mm length of vein, suspended with silk thread)
in 10 ml organ baths containing Krebs solution,
gassed with 95% O2e5% CO2, and maintained at
37 1 C. Rings were placed under an initial tension
of 2 g and longitudinal muscle 2.5 g and allowed to
equilibrate for 60 min. Mechanical activity was re-
corded using PowerLab Chart for Windows (version
4; ADInstruments, Australia). NA (108 to 103 M)
was applied cumulatively. ATP (106 to 103 M) and
a,b-methylene ATP (a,b-meATP; 108 to 105 M)
were applied non-cumulatively, separated by 15 min
intervals, washing in between. Increasing concentra-
tions of KCl (105 to 3 101 M) were also applied.
On separate segments the effect of P2Y receptor ag-
onists was examined cumulatively. 2-Methylthio ADP
(2-MeSADP; 108 to 105 M), repeated in the presence
of MRS2179 (106 M); UDP (106 to 103 M), repeated
in the presence of cibacron blue 3GA (104 M); UTP
(106 to 103 M) repeated in the presence of suramin
(104 M). All antagonists were incubated for 45 min.
Electrical field stimulation (100 V, 1e6 Hz, 0.1 msec
duration for 1 min every 10e20 min) of longitudinal
muscle was tested using platinum wire electrodes,
one in the lumen and one outside the vessel, via aGrass
SD9 stimulator and frequency response curves were
constructed in the absence and presence of prazosin
(106 M) alone, prazosin and pyridoxalphosphate-6-
azophenyl-20,40-disulphonic acid (PPADS; 3 105 M)
together and finally in the presence of tetrodotoxin
(TTX; 106 M). All agonists were equilibrated for
30 min.
The integrity of the endothelium was examined in
control and varicosed samples by their ability to relax
to acetylcholine (ACh). Vessels were precontracted
with NA (EC50 concentration) and increasing concen-
trations of ACh were applied (109e103 M).
Statistical analysis
Concentration-response curves were prepared using
the software Prism 3.0 (GraphPad Software, Inc., San
Diego, CA, USA). Significance was tested using
a two-way analysis of variance (ANOVA) followedby a post hoc test (Bonferroni’s). A probability of
P< 0.05 was taken as significant.
Results
An un-paired two-tailed t-test revealed a significant
age difference between the two groups (P< 0.0001),
the control group being older.
Histology
Sections stained with H&E confirmed previous find-
ings of smooth muscle variation in varicose sections
between atrophic and hypertrophic segments.3 Atro-
phic sections had reduced ECM and SMC content re-
sulting in a thin vein wall where individual layers
could not be distinguished. In hypertrophic segments
an increase in ECM broke up the smooth muscle bun-
dles. The intima was often thickened with hyperplasia
and hypertrophy of the longitudinal SMC, consistent
with an earlier report.4
Using smooth muscle actin and P2 receptor anti-
bodies, double staining identified P2X1, P2Y1, P2Y2,
P2Y4 and P2Y6 receptors on longitudinal and circular
smooth muscle. There was no immunostaining for
P2X2e6 or P2Y11 receptors. P2X1 receptor staining in-
tensity was decreased in varicose (Fig. 1b) compared
to control veins (Fig. 1a). Conversely, P2Y1 receptor
staining intensity was increased in varicose (Fig. 1f)
compared to control veins (Fig. 1e). P2Y2 receptor
staining (Fig. 2a and b) was weak in both tissue
groups, but its intensity was increased on intimal lon-
gitudinal muscle in most varicose veins. P2Y4 (Fig. 2e
and f) and P2Y6 (Fig. 3a and b) receptors stained with
similar intensities in control and varicose sections.
Preabsorption of the primary antibody with its cor-
responding peptide eliminated immunofluorescence
for all receptors in control and varicose vein
(Fig. 1c,d,g,h, 2c,d,g,h, 3c and d).
The boxed areas in Fig. 1a and f are represented
in Fig. 4 at increased magnification. The red P2X1
staining (Fig. 4a) and the green smooth muscle actin
staining (Fig. 4b) on the same section are shown.
Colocalization of actin and P2X1 receptors appear
yellow (Fig. 4c) Similarly, P2Y1 receptors (red;
Fig. 4d) and actin (green; Fig. 4e) are colocalised
(yellow; Fig. 4f).
Electron microscopy
Structures were identified in healthy (control) veins
characteristic of a smooth muscle contractile pheno-
type, including numerous myofilaments that attachEur J Vasc Endovasc Surg Vol 33, February 2007
242 M. J. Metcalfe et al.Fig. 1. Immunofluorescent staining of transverse sections of LSV. P2X1 receptors on control (a) and varicose (b) veins, and
P2Y1 receptors on control (e) and varicose (f) veins. P2X1 preabsorption control of control (c) and varicose (d) veins, P2Y1
controls of control (g) and varicose (h) veins. (L¼ lumen, I¼ intima, M¼media, A¼ adventitia). Boxed areas in (a) and (f)
represent areas magnified in Fig. 4 (aef, respectively).Eur J Vasc Endovasc Surg Vol 33, February 2007
243P2 Receptor Expression in Varicosed Long Saphenous VeinFig. 2. Immunofluorescent staining of transverse sections of LSV. P2Y2 receptors on control (a) and varicose (b) veins, and
P2Y4 receptors on control (e) and varicose (f) veins. P2Y2 preabsorption control of control (c) and varicose (d) veins, and
P2Y4 controls for control (g) and varicose (h) veins. (L¼ lumen, I¼ intima, M¼media, A¼ adventitia).Eur J Vasc Endovasc Surg Vol 33, February 2007
244 M. J. Metcalfe et al.Fig. 3. Immunofluorescent staining of transverse sections of LSV. P2Y6 receptors on control (a) and varicose (b) veins. P2Y6
preabsorption controls for control (c) and varicose (d) veins. (L¼ lumen, I¼ intima, M¼media, A¼ adventitia).to dense bodies within the cytoplasm and in dense
areas of the plasma membrane that alternate with cav-
eolae. Organelles (including mitochondria and golgi
complexes) are located in the perinuclear region
(Fig. 5a). SMC were tightly packed in organised bun-
dles and surrounded by fibrous tissue (Fig. 6a).
Varicose SMC had properties characteristic of a syn-
thetic phenotype. Whilst some varicose SMC showed
characteristics similar to control, other varicose SMC
contained an increased volume of organelles (includ-
ing vesicles and dilated rough endoplasmic reticu-
lum) located at the periphery of the cell (Fig. 5b).
These cells, though synthetic in appearance, were con-
firmed as being a SMC by the presence of a continuous
basal lamina with caveolae and a limited appearance
of myofilaments and dense bodies. The varicose SMC
showing synthetic properties were located around the
intimal and inner medial layers. Due to the disorgani-
sation of muscle fibres seen in varicose veins, it was
not possible to distinguish whether they were longitu-
dinal or circular fibres. No synthetic phenotyped SMC
was seen in the adventitia. Low magnification of the
varicose sections revealed an increase in collagen
and elastic tissue separating the muscle bundles, com-
pared to control sections (Fig. 6b).Eur J Vasc Endovasc Surg Vol 33, February 2007Functional experiments on circular smooth muscle
LSV circular muscle contracted to NA and KCl, and
contractions were reduced in the varicose tissue
(P< 0.0001 and P¼ 0.0338, respectively) (Fig. 7a).
Circular muscle contracted to ATP (P¼ 0.0178) and
a,b-meATP (P¼ 0.0292) (Fig. 7b), contractions were
significantly reduced in the varicose tissue.
ACh failed to induce relaxation of NA (EC50 con-
centration) precontracted control or varicose vessels,
suggesting that the endothelium was significantly dis-
rupted (figure not shown).
Functional experiments on longitudinal smooth muscle
Longitudinal muscle in healthy and varicose vein con-
tracted to purinoceptor and adrenoceptor agonists.
There was a significant reduction in contractions of
the varicose tissue to NA (P< 0.0001), KCl (P¼
0.0324), ATP (P< 0.0001) and a,b-meATP (P¼ 0.0033)
(Fig. 7c and d).
Unlike circular muscle, longitudinal muscle con-
tracted to several P2Y receptor agonists. Significant re-
ductions in contractions were again seen in varicose
245P2 Receptor Expression in Varicosed Long Saphenous VeinFig. 4. Immunostaining of transverse sections of LSV, outlined by boxes in Fig. 1(a and f). P2X1 receptors (red) in control vein
(a) and P2Y1 receptors (red) in varicose vein (d). Smooth muscle actin (green) (b, e). Colocalisation (yellow/orange) of P2X1
receptors (c) and P2Y1 receptors (f) and actin on SMC.tissue to 2-MeSADP (P¼ 0.0091), UTP (P¼ 0.0369)
and UDP (P¼ 0.292) (Fig. 8aec) compared to control
tissue.
In both control and varicose tissue, contractions to
2-MeSADP were significantly reduced (P¼ 0.0001
and P¼ 0.0125, respectively) in the presence of
MRS2179 (106 M). Contractions to UDP were also
significantly reduced in the presence of cibacron blue
3GA (104 M) (varicose tissue, P< 0.0001 and control
tissue, P¼ 0.0008) (Fig. 8d and e). Contractions to
UTP were inhibited by suramin (104 M) (control
(P¼ 0.0009) and varicose (P¼ 0.0023). UTP is an ago-
nist at both P2Y2 and P2Y4 receptors, however suramindistinguishes between suramin-sensitive P2Y2 and
suramin-insensitive P2Y4 receptors.
9
Electrical field stimulation induced frequency-
dependent contractions of longitudinal muscle. Prazo-
sin significantly reduced contractions (P< 0.0001)
and PPADS reduced contractions even further
(P¼ 0.0481). TTX demonstrated that responses were
nerve-mediated (Fig. 8f).
Discussion
There was a significant age difference between the
control and varicose vein groups, with more femalesEur J Vasc Endovasc Surg Vol 33, February 2007
246 M. J. Metcalfe et al.Fig. 5. Electron micrograph of SMC demonstrating the contractile phenotype in control veins (a) and the synthetic pheno-
type in varicose veins (b). Organelles appear perinuclear in the contractile phenotype, and towards the cell periphery in the
synthetic phenotype. (Cav¼ caveolae, RER¼ rough endoplasmic reticulum, DB¼ dense bodies).
Fig. 6. Electron micrograph of longitudinal sections of LSV comparing the closely bound muscle bundles in control vein
(a) with the SMC that are separated by an increase in the extracellular matrix in varicose vein (b). (ECM¼ extracellular
matrix, Long¼ intimal longitudinal muscle, Circ¼ circular muscle).Eur J Vasc Endovasc Surg Vol 33, February 2007
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Fig. 7. Concentration-response curves of circular (a, b) and longitudinal (c, d) smooth muscle of control and varicose human
long saphenous vein. NA (108 to 103 M) and KCl (105 to 3 101 M) contractions (a, c), and a,b-meATP (108 to 105 M)
and ATP (106 to 103 M) contractions (b, d) are shown. All symbols represent mean SE (unless masked by the symbol).in the varicose group as oestrogen is a causal factor.18
During pregnancy, varicose vein presentation in-
creases with plasma oestrogen levels, but usually re-
solves post partum. Contributing factors during
pregnancy may include impaired venous drainage
from the lower limbs. Oestrogen receptors have been
identified on varicose and control LSV19 and are
thought to affect vascular wall strength by relaxing
smooth muscle and softening collagen fibres. Haynes
et al.20 showed that oestrogen increases P2X1 and P2X7
receptor-mediated contractions in uterine arteries.
UTP was more potent in oestradiol-treated animals
by an upregulation of a UTP-specific pyrimidine re-
ceptor subtype.
Hypertrophy of the intimal longitudinal muscle
layer in varicose veins is consistent with previous stud-
ies.21 An increase in cell size with no changes in cell
number, suggesting hypertrophy but not hyperplasia
has been reported in hypertensive rat portal vein.22
Theories for the intimal changes include hypoxia of
the endothelial cells23 and endothelium disruption
causing SMC exposure to blood flow leading to modu-
lation of its function.24 Thiswas suggestedbyLee et al.25
and supported by increases in SMC and ECM (colla-
gen) in the LSV.26 It has been proposed that varicosechanges are due to modulation of their normal func-
tion.21 The separation of the SMC by increased ECM
in the hypertrophic intima suggests they have prolifer-
ative and synthetic functions andhaveadoptedadiffer-
ent phenotype.3 Aortocoronary saphenous vein grafts
have intimal hyperplasia in response to mechanical in-
jury andhaemodynamicdisturbances.3A similar phys-
iological exposure occurs in the LSV due to increased
venous pressure, perhaps promoting the SMC to
change phenotype. Buja´n et al.27 found a higher meta-
bolism of the elastic component in varicose veins due
to a restructuring of the elastic component of the vein
wall, as a consequence of alterations in the transcription
mechanisms of muscle cells.
The electron microscopy findings in control veins
were characteristic of contractile SMC as previously
reported.17 Populations of poorly differentiated SMC
with an increase in secretory cytoplasmic organelles
and a reduction in filament bundles, characteristics
seen in synthetic phenotyped SMC, have been previ-
ously noted in LSV, 17 in addition to phagocytic and se-
cretory properties.4,5 The ECM seen in varicose veins
could be synthesised via synthetic phenotyped SMC.
In the varicose vein wall, a significant increase in
transforming growth factor b1 (which stimulates theEur J Vasc Endovasc Surg Vol 33, February 2007
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Fig. 8. Concentration response-curves of control and varicose longitudinal smooth muscle from human long saphenous vein
to P2 receptor agonists, and in the absence and presence of P2 receptor antagonists. (a) 2-MeSADP (108 to 105 M); (b) UTP (106
to 103 M); (c) UDP (106 to 103 M). Concentration response curves to the P2Y6 receptor agonist UDP (10
6 to 103 M) in the
absence and presence of cibacron blue 3GA (104 M) in control (d) and varicose (e) LSV. (f) Electrical field stimulation of
longitudinal smooth muscle in control LSV in the absence and presence of prazosin (106 M), then in the presence of
prazosin and PPADS (3 105 M). All symbols represent mean SE (unless masked by symbol).synthesis of ECM components, especially collagens
and elastin, reduces the expression of matrix metal-
loproteinases and increases expression of tissue
inhibitors) and an increase in the cytokine basic
fibroblast growth factor (known to be chemotactic
and mitogenic for SMC) has been reported, with
no variation in vascular endothelial growth factor.3
Inflammatory cells could not account for the cyto-
kine modulation, as they were not present. These
three mechanisms could increase the ECM in vari-
cose veins.Eur J Vasc Endovasc Surg Vol 33, February 2007Previous studies on LSV have shown reduced con-
tractility of the circular muscle in the varicose state to
vasoconstrictors.6,28 P2X1, P2Y2, P2Y6 receptors have
been identified on the circular smooth muscle14,15,28
but for the first time we show a reduction in contrac-
tility through P2X1 receptors in the varicose tissue as
well as to NA and KCl, which is consistent with pre-
vious studies.6,28 Reduced contractions may result
from a combination of decreased muscle volume
and weaker contractile muscle cells in the varicose
vein.
249P2 Receptor Expression in Varicosed Long Saphenous VeinFor the first time contractions of the longitudinal
smooth muscle of human LSV was demonstrated
and shown to be mediated by P2X1, P2Y1, P2Y2 and
P2Y6 receptors. mRNA for P2Y1 receptors has been
detected on endothelium29 and endothelium-denuded
healthy LSV,30 but no contractile property has been
demonstrated. Endothelial P2Y1 receptors usually me-
diate vasodilatation, however, P2Y1 receptors here
mediate contraction of the longitudinal muscle, albeit
reduced in varicose tissue. Contractile properties of
longitudinal muscle has been previously reported in
the human coronary artery and rat portal vein.31,32
SMCand endothelial cell proliferation, death and se-
cretory properties are important in new vessel growth,
during wound healing and with intimal thickening
during arterial diseases.33,34 Purinoceptors play impor-
tant roles in the signalling pathways of these events.8,35
Vasoconstriction in blood vessels is mediated mainly
by P2X1 receptors and by P2Y2, P2Y4 and P2Y6 recep-
tors,7,36 while mitogenic effects of SMC are mediated
by P2Y1, P2Y2, P2Y4 and P2Y6 receptors.
7,35 Transition
from contractile to synthetic SMC phenotypes has
been shown in atherosclerosis, restenosis after angio-
plasty and during cell culture in vitro.35,37mRNA levels
of P2Y1 andP2Y2 receptors increase 342-fold and8-fold,
respectively, in cultured rat aortic smooth muscle cells
that show the synthetic phenotype when compared to
phenotypic contractile cells in freshly dissociatedmus-
cle.38 P2X1 receptor mRNAwas detected in contractile
cells but not in synthetic cells. mRNA levels of P2Y4
and P2Y6 receptors were similar in both cell pheno-
types. P2Y4 and P2Y6 receptor activation stimulatesmi-
togenesis in SMC.39,40 The SMC in varicose LSV show
similar changes in expression, i.e. reduced P2X1 recep-
tor immunostaining and P2X1-mediated contraction
P2Y1 and P2Y2 receptor immunostaining intensity
increased, associated with increased synthetic and
proliferative activity, and loss of contractile activity.
Immunostaining intensity remained constant for P2Y4
and P2Y6 receptors, although there was a reduction in
P2Y6 receptor-mediated contractions in varicose veins.
Endothelial cell production of nitric oxide and in-
creased sensitivity of the smooth muscle is thought
to lead to increased synthesis of cyclic GMP and
heightened vascular relaxation.41 A mitogenic pheno-
type may account for this altered sensitivity. In aortic
SMC, A2B receptor activation inhibits growth,
42 and
either P2Y2 or P2Y4 receptor activation stimulates
cell proliferation.43 In atherosclerosis, there is an upre-
gulation of P2Y2 receptors by a mitogen-activated pro-
tein kinase (MAPK)-dependent growth factor.
Suramin inhibits platelet derived growth factor
(PDGF) receptor activation and signalling through
the MAPK-activator protein 1 pathway. PDGF isa growth factor antagonist inhibiting cell proliferation
and reducing neointimal thickness in LSV grafts in
mice.44 These findings suggest an increased P2Y2 re-
ceptor expression in a hypertrophied intima, similar
to our demonstration of increased P2Y2 receptor ex-
pression in varicose intima.
Intimal longitudinal smooth muscle is more prom-
inent in hypertrophied varicose vein segments as
described in this study. We propose that intimal longi-
tudinal smooth muscle undergoes a change from
contractile to synthetic phenotype in varicose veins.
This is supported by the increase in intimal smooth
muscle volume, a reduction in its contractile strength,
increases in intimal ECM, increased intensity of
intimal P2Y1 and P2Y2 receptor staining and reduced
intimal P2X1 receptor staining.
What is the source of the ATP that acts on the P2
receptors expressed on the smooth muscle of LSV?
ATP may be released as a cotransmitter with NA
from perivascular sympathetic nerves,45 or released
from endothelial cells during changes in flow (shear
stress) and hypoxia.46 A further question that will
need to be resolved is whether the changes in smooth
muscle phenotype and associated changes in puriner-
gic signalling are causal or consequential in varicose
vein development.
An understanding of these changes occurring
within the purinergic signalling pathway may iden-
tify targets for therapeutic intervention. Modulation
of vein muscle phenotype may be a useful approach
for treating varicose veins and subsequent chronic ve-
nous insufficiency. It could potentially optimise the
role of the long saphenous vein as a bypass graft.
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